treatment of succinic semialdehyde dehydrogenase deficiency
All entries for: Galibra Neuroscience
July 28, 2026
Galibra Neuroscience
Orphan Drug Designation
Chestnut Hill
1-50 employees
Disease Area: Rare Diseases
treatment of succinic semialdehyde dehydrogenase deficiency